From bench to bedside – A mission for a healthy life

From bench to bedside – A mission for a healthy life

The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.

More about us to our events
Oxford-Berlin_2020

Please register

News

News |

Wolfgang Schulze Preis: Fristverlängerung − Forschungsvorhaben können bis 31.3.2020 eingereicht werden

Lecture |

This was the Avrion Mitchison Award and Albrecht Hasinger Lecture 2019

All News

Scientific Seminars

28
January 20
Seminar | Lab-Seminar

Roodline Cineus: Oncostatin M in intestinal inflammation

11
February 20
Seminar | Lab-Seminar

Annette Lahmann: Tissue-resident B cells in an airway inflammation model

11
February 20
Seminar | Epidemiologisches Doktorandenseminar

Laure Montag: Medikamentenlast bei jungen Erwachsenen mit JIA

18
February 20
Seminar | Lab-Seminar

Johanna Calhoff: Real life data in rheumatology

25
February 20
Seminar | Lab-Seminar

Jonathan Stefanowsky: Mechanisms of bone regeneration using longitudinal intravital microscopy

10
March 20
Seminar | Epidemiologisches Doktorandenseminar

Sabine Kirchner: Adherence to treatment – Validation of the PARQ/ CARQ questionnaire

21
April 20
Seminar | Epidemiologisches Doktorandenseminar

Florian Milatz: Aktivitätsmonitoring bei Jugendlichen und jungen Erwachsenen mit rheumatisch-muskuloskelettalen Erkrankungen

All Seminars

Research Topics at DRFZ

Rheumatic Diseases

Rheumatism - a disease with many faces

Paediatric Rheumatology

Rheumatic disease in children and adolescents

Immunological Memory
Drug Safety

How safe and effective are new therapies in clinical routine?

Intestinal Microbiota & Immune System

Dialog between the intestinal microflora and the immune system

Healthcare Research
Icon
107
PhD and MD students
Icon
90
Scientific researchers
Icon
114
Administration and infrastructure staff

Working at the DRFZ

The DRFZ is an equal opportunities employer. We do not discriminate against race, gender or ability. Applications from under-represented groups who meet the recruitment requirements are especially welcome.

 

Jobs

Research Groups

pb1

Baumgrass lab

Regulation of cytokine expression in different T cell subsets

A detailed molecular understanding of the mechanisms of T lymphocyte activation and activation-induced cell fate decisions will contribute to understanding their role in the induction and perpetuation of chronic inflammation, and eventually allow a window to address them therapeutically. read more

Program area 1 Program area 2 Program area 3 Shared Resource Laboratories
Leibniz ScienceCampus Berlin Chronic Inflammation

Investigating the causes of chronic inflammation

Doctors and researchers at the Charité – Universitätsmedizin Berlin and the Leibniz-Institute Deutsches Rheuma-Forschungszentrum Berlin have been working together since 2016 to investigate the wide-ranging causes of chronic inflammation and to find new ways to treat these diseases. The Leibniz Association has established the Leibniz ScienceCampus Chronic Inflammation and is supporting it with 1.2 million euros for 4 years.

more about the ScienceCampus

30 Jahre Deutsches Rheuma-Forschungszentrum Berlin Das Deutsche Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, wurde vor 30 Jahren, 1988, durch das Land Berlin gegründet, dem es für die vielen Jahre der großzügigen Unterstützung und konstruktiven Begleitung zu großem Dank verpflichtet ist.